| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Departments of Visual Neuroscience and 2Mathematics, Imperial College London, London, United Kingdom.
PURPOSE. Amblyopia is the commonest visual disorder of childhood. Yet the contributions of the two principal treatments (spectacle wear and occlusion) to outcome are unknown. This study was undertaken to investigate the dose-response relationship of amblyopia therapy.
METHODS. The study comprised three distinct phases: baseline, in which repeat measures of visual function were undertaken to confirm the initial visual deficit; refractive adaptation: an 18-week period of spectacle wear with six weekly measurements of logarithm of the minimum angle of resolution (logMAR) visual acuity; occlusion: in which participants were prescribed 6 hours of "patching" per day. In the latter phase, occlusion was objectively monitored and logMAR visual acuity recorded at 2-week intervals until any observed gains had ceased.
RESULTS. Data were obtained from 94 participants (mean age, 5.1 ± 1.4 years) with amblyopia associated with strabismus (n = 34), anisometropia (n = 23), and both anisometropia and strabismus (n = 37). Eighty-six underwent refractive adaptation. Average concordance with patching was 48%. The relationship between logMAR visual acuity gain and total occlusion dose was monotonic and linear. Increasing dose rate beyond 2 h/d hastened the response but did not improve outcome. More than 80% of the improvement during occlusion occurred within 6 weeks. Treatment outcome was significantly better for children younger than 4 years (n = 17) than in those older than 6 years (n = 24; P = 0.0014).
CONCLUSIONS. Continuous objective monitoring of the amount of patching therapy received has provided insight into the dose-response relationship of occlusion therapy for amblyopia. Patching is most effective within the first few weeks of treatment, even for those in receipt of a relatively small dose. Further studies are needed to elucidate the neural basis for the dose-response functions.
This article has been cited by other articles:
|
|
 |
|
  D Buck, C Powell, P Cumberland, H Davis, E Dawson, J Rahi, J Sloper, R Taylor, P Tiffin, M P Clarke, et al. Presenting features and early management of childhood intermittent exotropia in the UK: inception cohort study Br J Ophthalmol, December 1, 2009; 93(12): 1620 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E Mitchell and F. Sengpiel Neural mechanisms of recovery following early visual deprivation Phil Trans R Soc B, February 12, 2009; 364(1515): 383 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M Levi and R. W Li Improving the performance of the amblyopic visual system Phil Trans R Soc B, February 12, 2009; 364(1515): 399 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E Stewart, C. M Wilson, and A. R Fielder A 31/2 year old girl presenting with strabismus BMJ, January 21, 2009; 338(jan21_2): b68 - b68. [Full Text]
|
|
|
|
 |
|
 R. W Li, S. A Klein, and D. M Levi Prolonged Perceptual Learning of Positional Acuity in Adult Amblyopia: Perceptual Template Retuning Dynamics J. Neurosci., December 24, 2008; 28(52): 14223 - 14229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Li, A. Provost, and D. M. Levi Extended Perceptual Learning Results in Substantial Recovery of Positional Acuity and Visual Acuity in Juvenile Amblyopia Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5046 - 5051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E Loudon and H. J Simonsz Occlusion therapy for amblyopia BMJ, October 6, 2007; 335(7622): 678 - 679. [Full Text] [PDF]
|
|
|
|
|
|
C. E Stewart, D. A Stephens, A. R Fielder, M. J Moseley, and ROTAS Cooperative Objectively monitored patching regimens for treatment of amblyopia: randomised trial BMJ, October 6, 2007; 335(7622): 707 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Stewart, D. A. Stephens, A. R. Fielder, M. J. Moseley, and on behalf of the MOTAS Cooperative Modeling Dose-Response in Amblyopia: Toward a Child-Specific Treatment Plan Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2589 - 2594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Arnoldi Current Recommendations for Amblyopia Treatment Amer. Orthoptic Jrnl., January 1, 2007; 57(1): 60 - 67. [Abstract] [PDF]
|
|
|
|
|
|
S. E. Loudon, M. Fronius, C. W. N. Looman, M. Awan, B. Simonsz, P. J. van der Maas, and H. J. Simonsz Predictors and a remedy for noncompliance with amblyopia therapy in children measured with the occlusion dose monitor. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4393 - 4400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Stewart, A. R. Fielder, D. A. Stephens, M. J. Moseley, and MOTAS Cooperative Treatment of Unilateral Amblyopia: Factors Influencing Visual Outcome Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3152 - 3160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Li, K. G. Young, P. Hoenig, and D. M. Levi Perceptual Learning Improves Visual Performance in Juvenile Amblyopia Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3161 - 3168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Awan, F. A Proudlock, and I. Gottlob A Randomized Controlled Trial of Unilateral Strabismic and Mixed Amblyopia Using Occlusion Dose Monitors to Record Compliance Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1435 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Pediatric Eye Disease Investigator Group Randomized Trial of Treatment of Amblyopia in Children Aged 7 to 17 Years Arch Ophthalmol, April 1, 2005; 123(4): 437 - 447. [Abstract] [Full Text] [PDF]
|
|
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
